Early symptom improvement at 10 sessions as a predictor of rTMS treatment outcome in major depression

For DMPFC-rTMS, a '<20% improvement at 2 weeks' rule concurred with previous pharmacotherapy and ECT studies on predicting nonresponse, and could prove useful for treatment decision-making in clinical settings.